\-\ Texto\\:\\ \ \(0\)\
\-\ abdominal\\ distension\\,\\ elevated\\ circulating\\ estrogens\ \(0\)\
\-\ \\â\\€\\¢\\	surgical\\ resection\\ as\\ possible\\-\\ many\\ lesions\\ will\\ be\\ surgically\\ unresectable\\ or\\ inaccessible\\ such\\ as\\ at\\ the\\ mesenteric\\ root\\ \ \(0\)\
\-\ \\â\\€\\¢\\	surgical\\ v\\.\\ chemical\\ castration\\ \\(gnrh\\ analogues\\)\ \(0\)\
\-\ \\â\\€\\¢\\	aromatase\\ inhibitors\\ \\(anastrozole\\)\ \(0\)\
\-\ \\â\\€\\¢\\	goal\\-\\ symptomatic\\ improvement\ \(0\)\
\-\ \\â\\€\\¢\\	metastatic\\ degeneration\\ to\\ sarcoma\\-\\ only\\ 2\\-3\\ case\\ reports\\ in\\ literature\ \(0\)\
\-\ sagittal\\ t\\-2\\ weighted\\ and\\ axial\\ t\\-2\\ weighted\\ with\\ fat\\ suppression\\ mr\\ images\\ of\\ the\\ pelvis\\ demonstrate\\ multiple\\ subserosal\\ and\\ intramural\\ uterine\\ fibroids\\ with\\ too\\ numerous\\ to\\ count\\ intraperitoneal\\ masses\\ of\\ similar\\ homogenous\\ hypointensity\ \(0\)\
\-\ disseminated\\ peritoneal\\ leiomyomatosis\ \(0\)\
\-\ disseminated\\ peritoneal\\ leiomyomatosis\ \(0\)\
\-\ metastatic\\ peritoneal\\ leiomyomatosis\ \(0\)\
\-\ leiomyosarcoma\ \(24\)\
\-\ peritoneal\\ carcinomatosis\\ from\\ ovarian\\ or\\ other\\ source\\.\ \(0\)\
\-\ 40\\ year\\ old\\ woman\\ with\\ a\\ fibroid\\ uterus\\,\\ abdominal\\ fullness\\ and\\ urinary\\ frequency\\.\ \(1\)\
\-\ \\â\\€\\¢\\	takeda\\ t\\,\\ masuhara\\ k\\,\\ kamiura\\ s\\.\\ \\ successful\\ management\\ of\\ a\\ leiomyomatosis\\ peritonealis\\ disseminata\\ with\\ an\\ aromatase\\ inhibitor\\.\\ obstet\\ gynecol\\.\\ 2008\\ aug\\;112\\(2\\ pt\\ 2\\)\\:491\\-3\\.\ \(0\)\
\-\ \\â\\€\\¢\\	ueda\\ h\\,\\ togashi\\ k\\,\\ konishi\\ i\\ et\\ al\\.\\ unusual\\ appearances\\ of\\ uterine\\ leiomyomas\\:\\ mr\\ imaging\\ findings\\ and\\ their\\ histopathologic\\ backgrounds\\.\\ radiographics\\ 1999\\;\\ 19\\:\\ 131\\-45\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ leiomyomatosis\\:\\ 0\\.4299701359519751\ \(0\)\
\-\ peritoneal\\:\\ 0\\.2734731792344582\ \(0\)\
\-\ aromatase\\:\\ 0\\.23266328712806916\ \(0\)\
\-\ disseminated\\:\\ 0\\.15756749360325634\ \(0\)\
\-\ uterine\\:\\ 0\\.13586207151706542\ \(0\)\
\-\ estrogens\\:\\ 0\\.11633164356403458\ \(0\)\
\-\ inaccessible\\:\\ 0\\.11633164356403458\ \(0\)\
\-\ analogues\\:\\ 0\\.11633164356403458\ \(0\)\
\-\ anastrozole\\:\\ 0\\.11633164356403458\ \(0\)\
\-\ takeda\\:\\ 0\\.11633164356403458\ \(0\)\
\-\ masuhara\\:\\ 0\\.11633164356403458\ \(0\)\
\-\ kamiura\\:\\ 0\\.11633164356403458\ \(0\)\
\-\ peritonealis\\:\\ 0\\.11633164356403458\ \(0\)\
\-\ disseminata\\:\\ 0\\.11633164356403458\ \(0\)\
\-\ ueda\\:\\ 0\\.11633164356403458\ \(0\)\
\-\ togashi\\:\\ 0\\.11633164356403458\ \(0\)\
\-\ konishi\\:\\ 0\\.11633164356403458\ \(0\)\
\-\ backgrounds\\:\\ 0\\.11633164356403458\ \(0\)\
\-\ castration\\:\\ 0\\.11116109592228544\ \(0\)\
\-\ gnrh\\:\\ 0\\.11116109592228544\ \(0\)\
\-\ weighted\\:\\ 0\\.10852032996282808\ \(0\)\
\-\ obstet\\:\\ 0\\.10749253398799377\ \(0\)\
\-\ gynecol\\:\\ 0\\.10749253398799377\ \(0\)\
\-\ unresectable\\:\\ 0\\.10035623536517074\ \(0\)\
\-\ circulating\\:\\ 0\\.09865342441195298\ \(0\)\
\-\ subserosal\\:\\ 0\\.09865342441195298\ \(0\)\
\-\ leiomyomas\\:\\ 0\\.09715143870449548\ \(0\)\
\-\ 112\\:\\ 0\\.09580786670563753\ \(0\)\
\-\ mr\\:\\ 0\\.09413587166460566\ \(0\)\
\-\ aug\\:\\ 0\\.09348287677020382\ \(0\)\
\-\ histopathologic\\:\\ 0\\.09348287677020382\ \(0\)\
\-\ inhibitors\\:\\ 0\\.09246216099189272\ \(0\)\
\-\ appearances\\:\\ 0\\.09151712578912993\ \(0\)\
\-\ inhibitor\\:\\ 0\\.08904122119826856\ \(0\)\
\-\ suppression\\:\\ 0\\.0857533484160793\ \(0\)\
\-\ fibroids\\:\\ 0\\.08223052680581902\ \(0\)\
\-\ leiomyosarcoma\\:\\ 0\\.08223052680581902\ \(0\)\
\-\ hypointensity\\:\\ 0\\.08138006909134873\ \(0\)\
\-\ intramural\\:\\ 0\\.08097520525987136\ \(0\)\
\-\ fibroid\\:\\ 0\\.07983245850677366\ \(0\)\
\-\ metastatic\\:\\ 0\\.07979162195668425\ \(0\)\
\-\ abdominal\\:\\ 0\\.07956998188556542\ \(0\)\
\-\ chemical\\:\\ 0\\.07912382401000653\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.07878374680162817\ \(0\)\
\-\ intraperitoneal\\:\\ 0\\.07720740438465536\ \(0\)\
\-\ homogenous\\:\\ 0\\.07720740438465536\ \(0\)\
\-\ distension\\:\\ 0\\.07554171759026607\ \(0\)\
\-\ 2008\\:\\ 0\\.07430267191066472\ \(0\)\
\-\ fullness\\:\\ 0\\.07406868113372304\ \(0\)\
\-\ radiographics\\:\\ 0\\.07339141722977821\ \(0\)\
\-\ too\\:\\ 0\\.07317342663003125\ \(0\)\
\-\ 1999\\:\\ 0\\.07317342663003125\ \(0\)\
\-\ literature\\:\\ 0\\.07099334893073285\ \(0\)\
\-\ surgical\\:\\ 0\\.0707107900195505\ \(0\)\
\-\ successful\\:\\ 0\\.07063410997637307\ \(0\)\
\-\ source\\:\\ 0\\.0692905379775151\ \(0\)\
\-\ frequency\\:\\ 0\\.06913212426891557\ \(0\)\
\-\ root\\:\\ 0\\.06882108105481904\ \(0\)\
\-\ degeneration\\:\\ 0\\.06764764321698806\ \(0\)\
\-\ surgically\\:\\ 0\\.06750827418439635\ \(0\)\
\-\ unusual\\:\\ 0\\.06522957155768223\ \(0\)\
\-\ uterus\\:\\ 0\\.0638051066941291\ \(0\)\
\-\ improvement\\:\\ 0\\.06349781135355001\ \(0\)\
\-\ urinary\\:\\ 0\\.06290458162224853\ \(0\)\
\-\ mesenteric\\:\\ 0\\.06280833860276432\ \(0\)\
\-\ ovarian\\:\\ 0\\.06197335490979138\ \(0\)\
\-\ numerous\\:\\ 0\\.06144560485792491\ \(0\)\
\-\ their\\:\\ 0\\.060371975561573296\ \(0\)\
\-\ and\\:\\ 0\\.06012567242068294\ \(0\)\
\-\ count\\:\\ 0\\.06005902391593309\ \(0\)\
\-\ as\\:\\ 0\\.05844676413387448\ \(0\)\
\-\ al\\:\\ 0\\.05779860191363928\ \(0\)\
\-\ 19\\:\\ 0\\.05760587069515882\ \(0\)\
\-\ many\\:\\ 0\\.05735334482839698\ \(0\)\
\-\ et\\:\\ 0\\.0569836917129429\ \(0\)\
\-\ with\\:\\ 0\\.05697583302471206\ \(0\)\
\-\ of\\:\\ 0\\.056941810306622334\ \(0\)\
\-\ reports\\:\\ 0\\.056565551316444064\ \(0\)\
\-\ symptomatic\\:\\ 0\\.05593498000779741\ \(0\)\
\-\ sagittal\\:\\ 0\\.05593498000779741\ \(0\)\
\-\ similar\\:\\ 0\\.05544128714581152\ \(0\)\
\-\ management\\:\\ 0\\.053731752153655346\ \(0\)\
\-\ 40\\:\\ 0\\.05349861696660639\ \(0\)\
\-\ pt\\:\\ 0\\.05235059091740712\ \(0\)\
\-\ pelvis\\:\\ 0\\.05087678674528929\ \(0\)\
\-\ or\\:\\ 0\\.050611880214084075\ \(0\)\
\-\ elevated\\:\\ 0\\.049589765347094215\ \(0\)\
\-\ masses\\:\\ 0\\.049521934657636345\ \(0\)\
\-\ will\\:\\ 0\\.0468192405050535\ \(0\)\
\-\ such\\:\\ 0\\.046791904718484656\ \(0\)\
\-\ resection\\:\\ 0\\.04662910923670007\ \(0\)\
\-\ only\\:\\ 0\\.04544560236107837\ \(0\)\
\-\ fat\\:\\ 0\\.04525053714954188\ \(0\)\
\-\ axial\\:\\ 0\\.042018882560759786\ \(0\)\
\-\ lesions\\:\\ 0\\.041777040426786705\ \(0\)\
\-\ imaging\\:\\ 0\\.03822882625626202\ \(0\)\
\-\ woman\\:\\ 0\\.03788471094680456\ \(0\)\
\-\ demonstrate\\:\\ 0\\.03781698832586801\ \(0\)\
\-\ other\\:\\ 0\\.03777652671746071\ \(0\)\
\-\ case\\:\\ 0\\.03654521376490129\ \(0\)\
\-\ to\\:\\ 0\\.03637113617384183\ \(0\)\
\-\ findings\\:\\ 0\\.03590151119737377\ \(0\)\
\-\ multiple\\:\\ 0\\.03558010812930426\ \(0\)\
\-\ images\\:\\ 0\\.0336484082754086\ \(0\)\
\-\ be\\:\\ 0\\.02950886367084384\ \(0\)\
\-\ the\\:\\ 0\\.029029666343059625\ \(0\)\
\-\ from\\:\\ 0\\.02889037362200266\ \(0\)\
\-\ an\\:\\ 0\\.027816619330205176\ \(0\)\
\-\ at\\:\\ 0\\.027475893042369717\ \(0\)\
\-\ year\\:\\ 0\\.022417912306665504\ \(0\)\
\-\ old\\:\\ 0\\.021528955967324254\ \(0\)\
\-\ in\\:\\ 0\\.018096058758460695\ \(0\)\
